So they don't like what was reported you say but what I can't understand is why they liked so much the initial ann that was reported and managements observations and caution regarding these pending assay results. What came back was basically dead in line with management expectations. It's a methodical approach being undertaken here.
I'd say perhaps way too much hype based on the ann (and caution which accompanied initial news). Especially over at Devex. I like what these guys are doing but be careful not to say many investors don't. It's more probable it's your short term thrill holder who pushed this up that subsequently pulls it back down (again especially over at dev).
Looking forward to the next steps here at sovereign.
ASQ Price at posting:
10.5¢ Sentiment: Hold Disclosure: Held
